Actos (Type 2 Diabetes)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
3 Disease Overview 12
3.1 Etiology and Pathophysiology 12
3.1.1 Etiology 12
3.1.2 Pathophysiology 13
3.1.3 Prognosis 14
3.1.4 Quality of Life 15
3.2 Symptoms 15
4 Disease Management 17
4.1 Treatment Overview 17
4.1.1 Diagnosis and Referrals 17
4.1.2 Treatment Guidelines 18
5 Competitive Assessment 24
5.1 Overview 24
5.2 Strategic Competitor Assessment 25
6 Actos (pioglitazone) 27
6.1 Overview 27
6.2 Efficacy 28
6.3 Safety 29
6.4 SWOT Analysis 30
6.5 Forecast 31
7 Appendix 32
7.1 Bibliography 32
7.2 Abbreviations 35
7.3 Methodology 38
7.4 Forecasting Methodology 38
7.4.1 Diagnosed Type 2 Patients 38
7.4.2 Percent Drug-Treated Patients 39
7.4.3 Drugs Included in Each Therapeutic Class 39
7.4.4 Launch and Patent Expiry Dates 40
7.4.5 General Pricing Assumptions 41
7.4.6 Individual Drug Assumptions 42
7.4.7 Generic Erosion 42
7.5 Physicians and Specialists Included in this Study 43
7.6 About the Authors 45
7.6.1 Analyst II – CVMD 45
7.6.2 Therapy Director – CVMD and Infectious Disease 45
7.6.3 Global Head of Healthcare 46
7.7 About GlobalData 47
7.8 Disclaimer 47